{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T21:28:36Z","timestamp":1781990916265,"version":"3.54.5"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease (MAFLD) remains controversial. Additionally, little is known about the relationship between thyroid function parameters and MAFLD in the Chinese population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cross-sectional study involving 177,540 individuals with thyroid function tests and MAFLD diagnosis from 2010-2018. The association between thyroid function parameters and MAFLD was evaluated on a continuous scale with restricted cubic spline (RCS) models and by the prior-defined centile categories with multivariable-adjusted logistic regression models. Thyroid function parameters included free triiodothyronine (FT3), free tetra-iodothyronine (FT4), and thyroid stimulating hormone (TSH). Additionally, fully adjusted RCS models stratified by sex, age, and location were studied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the RCS models, the risk of MAFLD increased with higher levels of FT3 when FT3 &amp;lt;5.58pmol\/L, while the risk of MAFLD decreased with higher levels of FT3 when FT3 \u22655.58pmol\/L (P nonlinearity &amp;lt;0.05). While RCS analysis suggested that the FT4 levels had a negative association with MAFLD (P nonlinearity &amp;lt;0.05), indicating an increase in FT4 levels was associated with a decreased risk of MAFLD. RCS analysis suggested an overall positive association between the concentration of TSH and MAFLD risk (P nonlinearity &amp;lt;0.05). The rising slope was sharper when the TSH concentration was less than 1.79uIU\/mL, which indicated the association between TSH and MAFLD risk was tightly interrelated within this range. The multivariable logistic regression showed that populations in the 81st-95th centile had the highest risk of MAFLD among all centiles of FT3\/TSH, with the 1st-5th centile as the reference category.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study suggested nonlinear relationships between thyroid function parameters and MAFLD. Thyroid function parameters could be additional modifiable risk factors apart from the proven risk factors to steer new avenues regarding MAFLD prevention and treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1115354","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T09:26:59Z","timestamp":1677058019000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Yingying","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.cgh.2021.05.029","article-title":"Differential clinical characteristics and mortality outcomes in persons with nafld and\/or mafld","volume":"19","author":"Nguyen","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14675","article-title":"Mafld identifies patients with significant hepatic fibrosis better than nafld","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1511263","article-title":"Thyroid hormone (T(3)) stimulates brown adipose tissue activation Via mitochondrial biogenesis and mtor-mediated mitophagy","volume":"15","author":"Yau","year":"2019","journal-title":"Autophagy"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2014.07.001","article-title":"Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism","volume":"25","author":"Sinha","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.metabol.2016.11.002","article-title":"Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: The lifelines cohort study","volume":"67","author":"van den Berg","year":"2017","journal-title":"Metabolism"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04016.x","article-title":"Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese","volume":"75","author":"Xu","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1300","article-title":"Thyroid function and the risk of nonalcoholic fatty liver disease: The Rotterdam study","volume":"101","author":"Bano","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3109\/07435800.2014.987399","article-title":"Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects","volume":"40","author":"Liu","year":"2015","journal-title":"Endocr Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: A cross-sectional survey","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3760\/cma.j.cn112138-20211027-00751","article-title":"Chinese Elderly Type 2 Diabetes Prevention and Treatment of Clinical Guidelines Writing Group; Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Society; Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Health Care Society; Geriatric Professional Committee of Beijing Medical Award Foundation; National Clinical Medical Research Center for Geriatric Diseases (PLA General Hospital). Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 Edition)","volume":"61","year":"2022","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3760\/cma.j.issn.0253-3758.2020.01.004","article-title":"National guideline for hypertension management in China (2019)","volume":"48","year":"2020","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/1479164114562410","article-title":"Sex difference in the prevalence of metabolic syndrome and cardiovascular-related risk factors in urban adults from 33 communities of China: The chpsne study","volume":"12","author":"Song","year":"2015","journal-title":"Diabetes Vasc Dis Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154868","article-title":"Diabetes and metabolic dysfunction-associated fatty liver disease","volume":"123","author":"Davis","year":"2021","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00519-y","article-title":"Association of metabolic dysfunction-associated fatty liver disease with kidney disease","volume":"18","author":"Wang","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2021.04.008","article-title":"Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease","volume":"32","author":"Lim","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.821689","article-title":"A bidirectional relationship between hyperuricemia and metabolic dysfunction-associated fatty liver disease","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2015.21.4.372","article-title":"Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study","volume":"21","author":"Lee","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13070","article-title":"Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women","volume":"49","author":"Chen","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0012.3136","article-title":"Thyroid function and risk of non-alcoholic fatty liver disease in euthyroid subjects","volume":"17","author":"Liu","year":"2018","journal-title":"Ann Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3109\/07435800.2014.952014","article-title":"Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects","volume":"40","author":"Tao","year":"2015","journal-title":"Endocr Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2020.200219","article-title":"Serum thyroid hormones levels are significantly associated with nonalcoholic fatty liver disease in euthyroid Chinese population","volume":"66","author":"Zhang","year":"2020","journal-title":"Clin Lab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12902-021-00694-w","article-title":"Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0007","article-title":"Molecular aspects of thyroid hormone actions","volume":"31","author":"Cheng","year":"2010","journal-title":"Endocr Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.09.027","article-title":"Direct effects of iodothyronines on excess fat storage in rat hepatocytes","volume":"54","author":"Grasselli","year":"2011","journal-title":"J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312797","article-title":"Hypothyroidism-associated dyslipidemia: Potential molecular mechanisms leading to nafld","volume":"22","author":"Mavromati","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12080675","article-title":"Influence of altered thyroid hormone mechanisms in the progression of metabolic dysfunction associated with fatty liver disease (Mafld): A systematic review","volume":"12","author":"Marschner","year":"2022","journal-title":"Metabolites"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1707797114","article-title":"Pathogenesis of hypothyroidism-induced nafld is driven by intra- and extrahepatic mechanisms","volume":"114","author":"Ferrandino","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165927","article-title":"Hypothyroidism-induced nonalcoholic fatty liver disease (Hin): Mechanisms and emerging therapeutic options","volume":"21","author":"Tanase","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02874.x","article-title":"Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women","volume":"67","author":"De Pergola","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1159\/000129678","article-title":"Thyroid hormones and their relation to weight status","volume":"70","author":"Reinehr","year":"2008","journal-title":"Horm Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3505","article-title":"Paradoxical relationship between body mass index and thyroid hormone levels: A study using mendelian randomization","volume":"101","author":"Taylor","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0314","article-title":"Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects","volume":"24","author":"Roef","year":"2014","journal-title":"Thyroid"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2011.101","article-title":"Type I iodothyronine 5'-deiodinase mrna and activity is increased in adipose tissue of obese subjects","volume":"36","author":"Ortega","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2014.12.010","article-title":"Role of thyroid hormone homeostasis in obesity-prone and obesity-resistant mice fed a high-fat diet","volume":"64","author":"Xia","year":"2015","journal-title":"Metabolism"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0026","article-title":"High-fat diet increases thyrotropin and oxygen consumption without altering circulating 3,5,3'-triiodothyronine (T3) and thyroxine in rats: The role of iodothyronine deiodinases, reverse T3 production, and whole-body fat oxidation","volume":"151","author":"Araujo","year":"2010","journal-title":"Endocrinology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10863-011-9327-x","article-title":"Bioenergetic impact of tissue-specific regulation of iodothyronine deiodinases during nutritional imbalance","volume":"43","author":"Araujo","year":"2011","journal-title":"J Bioenerg Biomembr"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18189434","article-title":"Obesity and thyroid axis","volume":"18","author":"Walczak","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1530\/eje-14-0067","article-title":"Mechanisms in endocrinology: The crosstalk between thyroid gland and adipose tissue: Signal integration in health and disease","volume":"171","author":"Santini","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.962949","article-title":"Food preferences and thyroid hormones in children and adolescents with obesity","volume":"13","author":"Stan\u00edkov\u00e1","year":"2022","journal-title":"Front Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111629","article-title":"Pathophysiological molecular mechanisms of obesity: A link between mafld and Nash with cardiovascular diseases","volume":"22","author":"Guti\u00e9rrez-Cuevas","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32517-6","article-title":"Resmetirom (Mgl-3196) for the treatment of non-alcoholic steatohepatitis: A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1657","article-title":"Effects of resmetirom on noninvasive endpoints in a 36-week phase 2 active treatment extension study in patients with Nash","volume":"5","author":"Harrison","year":"2021","journal-title":"Hepatol Commun"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.cgh.2021.07.039","article-title":"Hepatic fat reduction due to resmetirom in patients with nonalcoholic steatohepatitis is associated with improvement of quality of life","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-108464","article-title":"Thyroid hormone (T3) and trbeta agonist gc-1 Inhibit\/Reverse nonalcoholic fatty liver in rats","volume":"22","author":"Perra","year":"2008","journal-title":"FASEB J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12998","article-title":"Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis b-infected subjects","volume":"30","author":"Ding","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11596-012-0008-8","article-title":"Relationship between serum tsh level with obesity and nafld in euthyroid subjects","volume":"32","author":"Zhang","year":"2012","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11739-011-0609-4","article-title":"Is nonalcoholic steatohepatitis associated with a high-Though-Normal thyroid stimulating hormone level and lower cholesterol levels","volume":"8","author":"Carulli","year":"2013","journal-title":"Intern Emerg Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23800","article-title":"A novel role for thyroid-stimulating hormone: Up-regulation of hepatic 3-Hydroxy-3-Methyl-Glutaryl-Coenzyme a reductase expression through the cyclic adenosine Monophosphate\/Protein kinase a\/Cyclic adenosine monophosphate-responsive element binding protein pathway","volume":"52","author":"Tian","year":"2010","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-978672","article-title":"Tsh receptor in adipose cells","volume":"32","author":"Sorisky","year":"2000","journal-title":"Horm Metab Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.5.8472","article-title":"Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (Ppargamma), and thyrotropin receptor by ppargamma agonist in human orbital preadipocyte fibroblasts","volume":"87","author":"Valyasevi","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511x-11-17","article-title":"Role of extrathyroidal tshr expression in adipocyte differentiation and its association with obesity","volume":"11","author":"Lu","year":"2012","journal-title":"Lipids Health Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1677\/joe.0.1760007","article-title":"Tsh stimulates leptin secretion by a direct effect on adipocytes","volume":"176","author":"Menendez","year":"2003","journal-title":"J Endocrinol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1530\/eje-10-0138","article-title":"Acute exogenous tsh administration stimulates leptin secretion in vivo","volume":"163","author":"Santini","year":"2010","journal-title":"Eur J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1115354\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T09:27:05Z","timestamp":1677058025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1115354\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":58,"alternative-id":["10.3389\/fendo.2023.1115354"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1115354","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"article-number":"1115354"}}